Executive Director of Vancouver Prostate Center Chosen as 'Local Hero' for Contributions to Fight Disease That Affects One in Six Men in Their Lifetime
VANCOUVER, April 21, 2011 (original story at CNW)
Steve Jones, President and CEO, Prostate Cancer Canada and members of the business community today celebrated Dr. Martin Gleave as a 'local hero' for his extraordinary contributions to fight prostate cancer.
Dr. Martin Gleave is Executive Director, Vancouver Prostate Centre at Vancouver General Hospital, Liber Ero BC Leadership Chair in Prostate Cancer Research, and Distinguished Professor , Department of Urologic Sciences, UBC. He was recognized at the 10th Annual 'Wake Up Call Breakfast, presented by TD Bank Group' and hosted by Donald McInnes, Vice Chair and CEO, Plutonic Power Corporation. Dr. Gleave was praised for his pioneering efforts to understand the cellular and molecular mechanisms leading to prostate cancer progression.
"Prostate Cancer Canada is proud to celebrate Dr. Gleave for his courage, inspiration and dedication to a disease that afflicts one in six Canadian men in their lifetime," Mr. Jones said. "Through his leadership as a scientist, surgeon and executive director, the Vancouver Prostate Centre is internationally recognized for excellence in prostate cancer research."
"I'm honoured to be receiving this award from Prostate Cancer Canada. Canadian researchers are making great advances in the fight against this disease and I'm proud to be part of it," Dr. Gleave said. "I'd also like to thank Prostate Cancer Canada for its leadership in raising awareness and funding critical research in Vancouver and across the country."
Breakfast attendees also heard The Honourable Wally Oppal, former Attorney-General of British Columbia, speak about his personal experiences as a prostate cancer survivor.
The Wake Up Call Breakfast is the only Canada-wide business breakfast series dedicated to the fight against prostate cancer. Over the past decade the event has attracted more than 16,000 business professionals and raised nearly $1.9 million for prostate cancer research, awareness, support and advocacy.
The 'Local Hero' award is the latest in a series of initiatives by Prostate Cancer Canada to advance its goal "to create a truly national organization that has the resources and strength in numbers to be an effective voice to make a difference in the lives of those affected by this disease," Mr. Jones added.
In March, PCC opened its first regional office in Halifax and announced a series of initiatives to strengthen the fight against prostate cancer throughout Atlantic Canada.
The Halifax office brings together 15 regional prostate cancer support groups under the Prostate Cancer Canada Network. "The decision of independent groups to affiliate with Prostate Cancer Canada is gaining momentum. We now have 58 support groups under our umbrella across the country," Mr. Jones noted.
Also in March, Prostate Cancer Canada released the results of a national online survey of 1,500 men and women designed to understand current knowledge about the disease. The survey showed that although the majority of Canadians are somewhat aware of the prevalence of prostate cancer, their specific knowledge of the main screening test - the PSA - was low. The majority of respondents, 58 per cent, said they knew little if anything about the test. Approximately 34 per cent reported that they had not heard of it.
Mr. Jones said the survey indicated that Canadians believe correctly that prostate cancer can be treated effectively if detected early. Even so, many men are delaying getting tested. A full 75 per cent of respondents believe that men could wait until 40 or over. Thirty-one (31) per cent believe men could wait until 50 years of age to get tested, a serious misunderstanding that could contribute to the mortality.
"Our survey reconfirmed the need for ongoing public awareness to help men and their loved ones better understand the risk of the disease and encourage men to get tested sooner than later," Mr. Jones said.